Shots: Pacira acquires MyoScience, in all stock transaction for $220M. MyoScience to receive $120M upfront and $100M as regulatory and commercial milestones. The transaction is expected to close in Apr’2019 The focus of an acquisition is to strengthen Pacira’s footprints in post-surgical analgesics by adding Myoscience’s iovera system to Pacira’s lead candidate Exparel Pacira is […]Read More
